Assessment of peripherally circulating plasma proteins and clinical risks todifferentiate epileptic seizure from psychogenic nonepileptic seizure
Ended Project Grant Awarded Last action
- Award ID
- R43NS113724
- Recipient
-
Evogen, Inc. UEI D1YYNB6DNBT3
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $594,137
Award facts
- Assistance listing
- 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
- Completion date
- Place of performance
- Kansas, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$22,982 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $55,000 | |
| Original award | $562,119 |
Quick answers
Who received award R43NS113724?
R43NS113724 was awarded to Evogen, Inc. by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on February 24, 2020.
How much is award R43NS113724 worth?
$594,137 has been obligated on R43NS113724.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award